Control of immune responses by immunoregulatory T cells

Archivum Immunologiae et Therapiae Experimentalis

Volumn 54, Issue 6, 2006, Pages 381-391

  Rudge, Geordie ^a   Gleeson, Paul A ^a   Van Driel, Ian R ^a  

^a UNIVERSITY OF MELBOURNE   (Australia)

Author keywords

Immunoregulation; Regulatory T cells; Tumor immunity

Indexed keywords

ANTIGEN; CYTOTOXIC T LYMPHOCYTE ANTIGEN 4; GLUCOCORTICOID INDUCED TUMOR NECROSIS FACTOR RECEPTOR; INTERLEUKIN 2 RECEPTOR ALPHA; RAG2 PROTEIN; T LYMPHOCYTE RECEPTOR; TRANSCRIPTION FACTOR FOXP3; TRANSFORMING GROWTH FACTOR ALPHA; TUMOR ANTIGEN;

ANTIGEN EXPRESSION; ANTIGEN PRESENTING CELL; ANTIGEN SPECIFICITY; CD25+ T LYMPHOCYTE; CD4+ CD25+ T LYMPHOCYTE; CD4+ T LYMPHOCYTE; CELL FUNCTION; DATA ANALYSIS; DENDRITIC CELL; DOWN REGULATION; EFFECTOR CELL; HUMAN; IMMUNE RESPONSE; IMMUNIZATION; IMMUNOREGULATION; LYMPHOCYTE DIFFERENTIATION; NONHUMAN; REGULATORY T LYMPHOCYTE; REVIEW; T LYMPHOCYTE; T LYMPHOCYTE ACTIVATION; T LYMPHOCYTE SUBPOPULATION; TUMOR IMMUNITY; UPREGULATION;

ANIMALS; BIOLOGICAL MARKERS; CD4-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELL SURVIVAL; EPITOPES; FORKHEAD TRANSCRIPTION FACTORS; HUMANS; IMMUNITY, CELLULAR; INTERLEUKIN-2 RECEPTOR ALPHA SUBUNIT; LYMPHOCYTE ACTIVATION; MALE; MICE; NEOPLASMS; T-LYMPHOCYTES, REGULATORY;

EID: 33845683913     PISSN: 0004069X     EISSN: 16614917     Source Type: Journal    
DOI: 10.1007/s00005-006-0045-8     Document Type: Review

References (101)

1. + T cells regulate the expansion of peripheral CD4 T cells through the production of IL-10. J. Immunol., 166, 3008-3018.
2. + T helper cells and hindered by naturally occurring T regulatory cells. J. Immunol., 174, 2591-2601.
3. Apostolou I., Sarukhan A., Klein L. and Von Boehmer H. (2002): Origin of regulatory T cells with known specificity for antigen. Nat. Immunol., 3, 756-763.
4. Asseman C., Mauze S., Leach M. W., Coffman R. L. and Powrie F. (1999): An essential role for interleukin 10 in the function of regulatory T cells that inhibit intestinal inflammation. J. Exp. Med., 190, 995-1004.
5. Barthlott T., Kassiotis G. and Stockinger B. (2003): T cell regulation as a side effect of homeostasis and competition. J. Exp. Med., 197, 451-460.
6. Belkaid Y., Piccirillo C. A., Mendez S., Shevach E. M. and Sacks D. L. (2002): CD4(+)CD25(+) regulatory T cells control Leishmania major persistence and immunity. Nature, 420, 502-507.
7. Bensinger S. J., Bandeira A., Jordan M. S., Caton A. J. and Laufer T. M. (2001): Major histocompatibility complex class II-positive cortical epithelium mediates the selection of CD4(+)25(+) immunoregulatory T cells. J. Exp. Med., 194, 427-438.
8. Caramalho I., Lopes-Carvalho T., Ostler D., Zelenay S., Haury M. and Demengeot J. (2003): Regulatory T cells selectively express Toll-like receptors and are activated by lipopolysaccharide. J. Exp. Med., 197, 403-411.
9. + T cells with IFN-gamma-dependent antiangiogenic activity, as well as long-lasting tumor immunity elicited by peptide vaccination. J. Immunol., 171, 5931-5939.
10. + regulatory T cells down-regulate co-stimulatory molecules on antigen-presenting cells. Eur. J. Immunol., 30, 1538-1543.
11. Chatila T. A., Blaeser F., Ho N., Lederman H. M., Voulgaropoulos C., Helms C. and Bowcock A. M. (2000): JM2, encoding a fork head-related protein, is mutated in X-linked autoimmunity-allergic disregulation syndrome. J. Clin. Invest., 106, R75-81.
12. Chen M. L., Pittet M. J., Gorelik L., Flavell R. A., Weissleder R., von Boehmer H. and Khazaie K. (2005): Regulatory T cells suppress tumor-specific CD8 T cell cytotoxicity through TGF-beta signals in vivo. Proc. Natl. Acad. Sci. USA, 102, 419-424.
13. + regulatory T cells by TGF-beta induction of transcription Factor Foxp3. J. Exp. Med., 198, 1875-1886.
14. Curiel T. J., Coukos G., Zou L., Alvarez X., Cheng P., Mottram P., Evdemon-Hogan M., Conejo-Garcia J. R., Zhang L., Burow M., Zhu Y., Wei S., Kryczek I., Daniel B., Gordon A, Myers L., Lackner A, Disis M. L., Knutson K. L., Chen L. and Zou W. (2004): Specific recruitment of regulatory T cells in ovarian carcinoma fosters immune privilege and predicts reduced survival. Nat. Med., 10, 942-949.
15. + regulatory T cells in the absence of interleukin 2 signaling. Nat. Immunol., 6, 1152-1159.
16. + regulatory T cell function. Eur. J. Immunol., 34, 2480-2488.
17. + T cells. Proc. Natl. Acad. Sci. USA, 101, 14473-14478.
18. + T lymphocytes. J. Immunol., 174, 155-163.
19. Fahlen L., Read S., Gorelik L., Hurst S. D., Coffman R. L., Flavell R. A. and Powrie F. (2005): T cells that cannot respond to TGF-beta escape control by CD4(+)CD25(+) regulatory T cells. J. Exp. Med., 201, 737-746.
20. - T cells through Foxp3 induction and down-regulation of Smad7. J. Immunol., 172, 5149-5153.
21. + regulatory T cells. Curr. Opin. Immunol., 16, 203-208.
22. + regulatory T cells in the steady state. J. Exp. Med., 198, 737-746.
23. Fontenot J. D., Gavin M. A. and Rudensky A. Y. (2003): Foxp3 programs the development and function of CD4(+)CD25(+) regulatory T cells. Nat. Immunol., 4, 330-336.
24. Fontenot J. D., Rasmussen J. P., Gavin M. A. and Rudensky A. Y. (2005): A function for interleukin 2 in Foxp3-expressing regulatory T cells. Nat. Immunol., 6, 1142-1151.
25. Furtado G. C., Curotto de Lafaille M. A., Kutchukhidze N. and Lafaille J. J. (2002): Interleukin 2 signaling is required for CD4(+) regulatory T cell function. J. Exp. Med., 196, 851-857.
26. Gavin M. A., Clarke S. R., Negrou E., Gallegos A. and Rudensky A. (2002): Homeostasis and anergy of CD4(+)CD25(+) suppressor T cells in vivo. Nat. Immunol., 3, 33-41.
27. + regulatory T cell proliferation. J. Exp. Med., 202, 919-929.
28. + regulatory cells uncovers immune responses to shared murine tumor rejection antigens. Eur. J. Immunol., 32, 3267-3275.
29. + T cell-mediated pulmonary hyperinflammation driven by Pneumocystis carinii in immunodeficient mice. Eur. J. Immunol., 32, 1282-1291.
30. + regulatory T cells in anti-myelin basic protein T cell receptor transgenic mice. Proc. Natl. Acad. Sci. USA, 99, 8213-8218.
31. Hori S., Nomura T. and Sakaguchi S. (2003): Control of regulatory T cell development by the transcription factor Foxp3. Science, 299, 1057-1061.
32. + T cell receptors. Immunity, 21, 267-277.
33. + regulatory T cells is antigen-specific and requires IL-10 and TGF-beta. J. Immunol., 175, 4283-4291.
34. + T cells. J. Immunol., 173, 6526-6531.
35. Itoh M., Takahashi T., Sakaguchi N., Kuniyasu Y., Shimizu J., Otsuka F. and Sakaguchi S. (1999): Thymus and autoimmunity: production of CD25(+)CD4(+) naturally anergic and suppressive T cells as a key function of the thymus in maintaining immunologic self-tolerance. J. Immunol., 162, 5317-5326.
36. Jaeckel E., von Boehmer H. and Manns M. P. (2005): Antigen-specific FoxP3-transduced T-cells can control established type 1 diabetes. Diabetes, 54, 306-310.
37. + regulatory cells results in suppression of melanoma growth and induction of autoreactivity in mice. Cancer Immun., 2, 1.
38. + regulatory T cells induced by an agonist self-peptide. Nat. Immunol., 2, 301-306.
39. Kawahata K., Misaki Y., Yamauchi M., Tsunekawa S., Setoguchi K., Miyazaki J. and Yamamoto K. (2002): Generation of CD4(+)CD25(+) regulatory T cells from autoreactive T cells simultaneously with their negative selection in the thymus and from nonautoreactive T cells by endogenous TCR expression. J. Immunol., 168, 4399-4405.
40. Khattri R., Cox T., Yasayko S. A. and Ramsdell F. (2003): An essential role for Scurfin in CD4(+)CD25(+) T regulatory cells. Nat. Immunol., 4, 337-342.
41. + regulatory T cells prevent graft rejection: CTLA-4- and IL-10-dependent immunoregulation of alloresponses. J. Immunol., 168, 1080-1086.
42. + regulatory T cells. J. Exp. Med., 202, 885-891.
43. Kretschmer K., Apostolou I., Hawiger D., Khazaie K., Nussenzweig M. C. and von Boehmer H. (2005): Inducing and expanding regulatory T cell populations by foreign antigen. Nat. Immunol., 6, 1219-1227.
44. Lee M. K., Moore D. J., Jarrett B. P., Lian M. M., Deng S., Huang X., Markmann J. W., Chiaccio M., Barker C. F., Caton A. J. and Markmann J. F. (2004): Promotion of silograft survival by CD4(+)CD25(+) regulatory T cells: evidence for in vivo inhibition of effector cell proliferation. J. Immunol., 172, 6539-6544.
45. + regulatory T cell repertoire formation in response to varying expression of a neo-self-antigen. J. Immunol., 173, 236-244.
46. Levings M. K., Sangregorio R. and Roncarolo M. G. (2001): Human CD25(+)CD4(+) T regulatory cells suppress naive and memory T cell proliferation and can be expanded in vitro without loss of function. J. Exp. Med., 193, 1295-1302.
47. Lin C. H. and Hunig T. (2003) Efficient expansion of regulatory T cells in vitro and in vivo with a CD28 superagonist. Eur. J. Immunol., 33, 626-638.
48. Liu Z., Geboes K., Hellings P., Maerten P., Heremans H., Vandenberghe P., Boon L., van Kooten P., Rutgeerts P. and Ceuppens J. L. (2001): B7 interactions with CD28 and CTLA-4 control tolerance or induction of mucosal inflammation in chronic experimental colitis. J. Immunol., 167, 1830-1838.
49. Lyon M. F., Peters J., Glenister P. H., Ball S. and Wright E. (1990): The scurfy mouse mutant has previously unrecognized hematological abnormalities and resembles Wiskott-Aldrich syndrome. Proc. Natl. Acad. Sci. USA, 87, 2433-2437.
50. Malek T. R., Yu A., Vincek V., Scibelli P. and Kong L. (2002): CD4 regulatory T cells prevent lethal autoimmunity in IL-2Rbeta-deficient mice. Implications for the nonredundant function of IL-2. Immunity, 17, 167-178.
51. Maloy K. J. and Powrie F. (2001) Regulatory T cells in the control of immune pathology. Nat. Immunol., 2, 816-822.
52. + T® cells suppress innate immune pathology through cytokine-dependent mechanisms. J. Exp. Med., 197, 111-119.
53. + cells in vivo. J. Immunol., 172, 3391-3398.
54. + regulatory T cells from nonobese diabetic mice. J. Immunol., 175, 3053-3059.
55. McHugh R. S., Whitters M. J., Piccirillo C. A., Young D. A., Shevach E. M., Collins M. and Byrne M. C. (2002): CD4(+)CD25(+) immunoregulatory T cells. Gene expression analysis reveals a functional role for the glucocorticoid- induced TNF receptor. Immunity, 16, 311-323.
56. + T cells. Proc. Natl. Acad. Sci. USA, 99, 8832-8837.
57. + regulatory T cell activity in both humans and mice. J. Immunol., 172, 834-842.
58. + T cells responding to serologically defined autoantigens suppress antitumor immune responses. Proc. Natl. Acad. Sci. USA, 100, 10902-10906.
59. Olivares-Villagomez D., Wang Y. and Lafaille J. J. (1998): Regulatory CD4(+) T cells expressing endogenous T cell receptor chains protect myelin basic protein-specific transgenic mice from spontaneous autoimmune encephalomyelitis. J. Exp. Med., 188, 1883-1894.
60. Onizuka S., Tawara I., Shimizu J., Sakaguchi S., Fujita T. and Nakayama E. (1999): Tumor rejection by in vivo administration of anti-CD25 (interleukin-2 receptor alpha) monoclonal antibody. Cancer Res., 59, 3128-3133.
61. Papiernik M., de Moraes M. L., Pontoux C., Vasseur F. and Penit C. (1998): Regulatory CD4 T cells: expression of IL-2R alpha chain, resistance to clonal deletion and IL-2 dependency. Int. Immunol., 10, 371-378.
62. Papiernik M., do Carmo Leite-de-Moraes M., Pontoux C., Joret A. M., Rocha B., Penit C. and Dy M. (1997): T cell deletion induced by chronic infection with mouse mammary tumor virus spares a CD25-positive, IL-10-producing T cell population with infectious capacity. J. Immunol., 158, 4642-4653.
63. + T cell-mediated suppression by dendritic cells. Science, 299, 1033-1036.
64. Paust S., Lu L., McCarty N. and Cantor H. (2004): Engagement of B7 on effector T cells by regulatory T cells prevents autoimmune disease. Proc. Natl. Acad. Sci. USA, 101, 10398-10403.
65. + regulatory T cells can mediate suppressor function in the absence of transforming growth factor betal production and responsiveness. J. Exp. Med., 196, 237-246.
66. + immunoregulatory cells. J. Immunol., 167, 1137-1140.
67. Read S., Malmstrom V. and Powrie F. (2000): Cytotoxic T lymphocyte-associated antigen 4 plays an essential role in the function of CD25(+)CD4(+) regulatory cells that control intestinal inflammation. J. Exp. Med., 192, 295-302.
68. Rouse B. T. and Suvas S. (2004): Regulatory cells and infectious agents: detentes cordiale and contraire. J. Immunol., 173, 2211-2215.
69. Sakaguchi S., Sakaguchi N., Asano M., Itoh M. and Toda M. (1995): Immunologic self-tolerance maintained by activated T cells expressing IL-2 receptor alpha-chains (CD25). Breakdown of a single mechanism of self-tolerance causes various autoimmune diseases. J. Immunol., 155, 1151-1164.
70. + immunoregulatory T cells that control autoimmune diabetes. Immunity, 12, 431-440.
71. + regulatory T cells in the regional lymph node. J. Exp. Med., 202, 771-781.
72. + T-cell pool and the expression of Foxp3 in vivo. Int. Immunol., 16, 1241-1249.
73. Seddon B. and Mason D. (1999): Peripheral autoantigen induces regulatory T cells that prevent autoimmunity. J. Exp. Med., 189, 877-882.
74. Setoguchi R., Hori S., Takahashi T. and Sakaguchi S. (2005): Homeostatic maintenance of natural Foxp3(+) CD25(+) CD4(+) regulatory T cells by interleukin (IL)-2 and induction of autoimmune disease by IL-2 neutralization. J. Exp. Med., 201, 723-735.
75. Shimizu J., Yamazaki S. and Sakaguchi S. (1999): Induction of tumor immunity by removing CD25(+)CD4(+) T cells: a common basis between tumor immunity and autoimmunity. J. Immunol., 163, 5211-5218.
76. + regulatory T cells through GITR breaks immunological self-tolerance. Nat. Immunol., 3, 135-142.
77. + T cells. J. Immunol., 173, 5008-5020.
78. Stephens L. A. and Mason D. (2000): CD25 is a marker for CD4(+) thymocytes that prevent autoimmune diabetes in rats, but peripheral T cells with this function are found in both CD25(+) and CD25(-) subpopulations. J. Immunol., 165, 3105-3110.
79. Suri-Payer E. and Cantor H. (2001): Differential cytokine requirements for regulation of autoimmune gastritis and colitis by CD4(+)CD25(+) T cells. J. Autoimmun., 16, 115-123.
80. Sutmuller R. P., van Duivenvoorde L. M., van Elsas A., Schumacher T. N., Wildenberg M. E., Allison J. P., Toes R. E., Offringa R. and Melief C. J. (2001): Synergism of cytotoxic T lymphocyte-associated antigen 4 blockade and depletion of CD25(+) regulatory T cells in antitumor therapy reveals alternative pathways for suppression of autoreactive cytotoxic T lymphocyte responses. J. Exp. Med., 194, 823-832.
81. Takahashi T., Kuniyasu Y., Toda M., Sakaguchi N., Itoh M., Iwata M., Shimizu J. and Sakaguchi S. (1998): Immunologic self-tolerance maintained by CD25(+)CD4(+) naturally anergic and suppressive T cells: induction of autoimmune disease by breaking their anergic/suppressive state. Int. Immunol., 10, 1969-1980.
82. Takahashi T., Tagami T., Yamazaki S., Uede T., Shimizu J., Sakaguchi N., Mak T. W. and Sakaguchi S. (2000): Immunologic self-tolerance maintained by CD25(+)CD4(+) regulatory T cells constitutively expressing cytotoxic T lymphocyte-associated antigen 4. J. Exp. Med., 192, 303-309.
83. + regulatory cells augments the generation of specific immune T cells in tumor-draining lymph nodes. J. Immunother., 25, 207-217.
84. Tanchot C., Vasseur F., Pontoux C., Garcia C. and Sarukhan A. (2004): Immune regulation by self-reactive T cells is antigen specific. J. Immunol., 172, 4285-4291.
85. Tang Q., Adams J. Y., Tooley A. J., Bi M., Fife B. T., Serra P., Santamaria P., Locksley R. M., Krummel M. F. and Bluestone J. A. (2006): Visualizing regulatory T cell control of autoimmune responses in nonobese diabetic mice. Nat. Immunol., 7, 83-92.
86. + regulatory T cells. J. Immunol., 171, 3348-3352.
87. + T cell suppressor function. J. Immunol., 172, 6519-6523.
88. + immunoregulatory T cells suppress polyclonal T cell activation in vitro by inhibiting interleukin 2 production. J. Exp. Med., 188, 287-296.
89. + immunoregulatory T cells is antigen nonspecific. J. Immunol., 164, 183-190.
90. +CD4 T cells in vivo after induction of peripheral tolerance with intravenous or oral antigen. J. Immunol., 167, 188-195.
91. Turk M. J., Guevara-Patino J. A., Rizzuto G. A., Engelhorn M. E. and Houghton A. N. (2004): Concomitant tumor immunity to a poorly immunogenic melanoma is prevented by regulatory T cells. J. Exp. Med., 200, 771-782.
92. van Santen H. M., Benoist C. and Mathis D. (2004): Number of T reg cells that differentiate does not increase upon encounter of agonist ligand on thymic epithelial cells. J. Exp. Med., 200, 1221-1230.
93. + regulatory T cells in vivo. J. Exp. Med., 198, 249-258.
94. + regulatory T cells and their ligands: implications for immunotherapy. Immunity, 20, 107-118.
95. + regulatory T cells in human thymus. Nature, 436, 1181-1185.
96. Wolf M., Schimpl A. and Hunig T. (2001): Control of T cell hyperactivation in IL-2-deficient mice by CD4(+)CD25(-) and CD4(+)CD25(+) T cells: evidence for two distinct regulatory mechanisms. Eur. J. Immunol., 31, 1637-1645.
97. Woo E. Y., Chu C. S., Goletz T. J., Schlienger K., Yeh H., Coukos G., Rubin S. C., Kaiser L. R. and June C. H. (2001): Regulatory CD4(+)CD25(+) T cells in tumors from patients with early-stage non-small cell lung cancer and late-stage ovarian cancer. Cancer Res., 61, 4766-4772.
98. Woo E. Y., Yeh H., Chu C. S., Schlienger K., Carroll R. G., Riley J. L., Kaiser L. R. and June C. H. (2002): Cutting edge: regulatory T cells from lung cancer patients directly inhibit autologous T cell proliferation. J. Immunol., 168, 4272-4276.
99. + cells unmasks tumor immunogenicity leading to the rejection of late-stage tumors. J. Exp. Med., 201, 779-791.
100. + CD25- CD4 T cells constitute a reservoir of committed regulatory cells that regain CD25 expression upon homeostatic expansion. Proc. Natl. Acad. Sci. USA, 102, 4091-4096.
101. + regulatory T cells inhibit the antigen-dependent expansion of self-reactive T cells in vivo. J. Immunol., 176, 1609-1617.